| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Acne Vulgaris | D000152 | 35 associated lipids |
| Hypersensitivity, Delayed | D006968 | 43 associated lipids |
| Liver Neoplasms, Experimental | D008114 | 46 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
lauric acid
lauric acid is a lipid of Fatty Acyls (FA) class. Lauric acid is associated with abnormalities such as Infection, Renal tubular disorder, Hypertensive disease, Obesity and Mycoses. The involved functions are known as Transcription, Genetic, Signal Transduction, Mutation, metaplastic cell transformation and Anabolism. Lauric acid often locates in Skin, Plasma membrane, Cytoplasmic matrix, Body tissue and Palmar surface. The associated genes with lauric acid are Gene Family, SLC33A1 gene, Homologous Gene, Open Reading Frames and P4HTM gene. The related lipids are Fatty Acids, Oleic Acids, Palmitates, Stearates and 9,11-linoleic acid.
Cross Reference
Introduction
To understand associated biological information of lauric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with lauric acid?
lauric acid is suspected in Renal tubular disorder, Hypertensive disease, Infection, Renal vascular disorder, Obesity, Mycoses and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Am. J. Clin. Nutr. (1)
- Am. J. Physiol. Heart Circ. Physiol. (1)
- Antimicrob. Agents Chemother. (1)
- Others (7)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with lauric acid
PubChem Associated disorders and diseases
What pathways are associated with lauric acid
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with lauric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with lauric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with lauric acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with lauric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with lauric acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with lauric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Pons N et al. | Interaction of polyhalogenated compounds of appropriate configuration with mammalian or bacterial CYP enzymes. Increased bilirubin and uroporphyrinogen oxidation in vitro. | 2003 | Biochem. Pharmacol. | pmid:12907239 |
| Kikuta Y et al. | Expression and induction of cytochrome P450s in rabbit parotid glands. | 2001 | Biochem. Pharmacol. | pmid:11389885 |
| Sharma RK et al. | Role of hepatic and renal cytochrome P-450 IVA1 in the metabolism of lipid substrates. | 1989 | Biochem. Pharmacol. | pmid:2554928 |
| Swinney DC et al. | A novel rat hepatic clofibrate-inducible cytochrome P450 that is not a lauric acid hydroxylase. | 1991 | Biochem. Pharmacol. | pmid:1662512 |
| Lundgren B et al. | Effects of dietary treatment with 11 dicarboxylic acids, diethylcarboxylic esters and fatty acids on peroxisomal fatty acid beta-oxidation, epoxide hydrolases and lauric acid omega-hydroxylation in mouse liver. | 1992 | Biochem. Pharmacol. | pmid:1540233 |
| Thomas H et al. | Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes. | 1989 | Biochem. Pharmacol. | pmid:2500933 |
| Byard J et al. | Novel approaches to the purification and identification of cytochrome P450 enzymes in the equine. | 1996 | Biochem. Soc. Trans. | pmid:8736866 |
| Gibson GG and Bains SK | Cytochrome P-450 isoenzymes involved in fatty acid metabolism. | 1985 | Biochem. Soc. Trans. | pmid:4065418 |
| Makowska JM et al. | Species differences in the hepatic response to a potent peroxisome proliferator. | 1989 | Biochem. Soc. Trans. | pmid:2628085 |
| Sherrington EJ et al. | Lack of effect of different dietary saturated fatty acids on adipose tissue deposition in the rat. | 1996 | Biochem. Soc. Trans. | pmid:8736816 |
| Abigor RD et al. | Lipase-catalysed production of biodiesel fuel from some Nigerian lauric oils. | 2000 | Biochem. Soc. Trans. | pmid:11171279 |
| Straub P et al. | Differential effects of mutations in substrate recognition site 1 of cytochrome P450 2C2 on lauric acid and progesterone hydroxylation. | 1994 | Biochemistry | pmid:8025107 |
| CaJacob CA and Ortiz de Montellano PR | Mechanism-based in vivo inactivation of lauric acid hydroxylases. | 1986 | Biochemistry | pmid:3490272 |
| Haines DC et al. | Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel. | 2008 | Biochemistry | pmid:18298086 |
| Gasymov OK et al. | Ligand binding site of tear lipocalin: contribution of a trigonal cluster of charged residues probed by 8-anilino-1-naphthalenesulfonic acid. | 2008 | Biochemistry | pmid:18179255 |
| Murataliev MB and Feyereisen R | Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain. | 1996 | Biochemistry | pmid:8942669 |
| Murataliev MB et al. | Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain. | 1997 | Biochemistry | pmid:9204888 |
| Lawson RJ et al. | Expression and characterization of the two flavodoxin proteins of Bacillus subtilis, YkuN and YkuP: biophysical properties and interactions with cytochrome P450 BioI. | 2004 | Biochemistry | pmid:15449930 |
| Sanghani PC et al. | Human glutathione-dependent formaldehyde dehydrogenase. Structures of apo, binary, and inhibitory ternary complexes. | 2002 | Biochemistry | pmid:12196016 |
| Orlowski M et al. | Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. | 1993 | Biochemistry | pmid:8431436 |